Page 3 - One Partnering News Today

Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives CHERRY HILL, N.J., January 4, 2023 - Vyant Bio, Inc. is an innovative biotechnology company reinventing... | January 4, 2023

DAEJEON, South Korea, Dec. 8, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the developme...

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...

/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...

FREDERICK, Md.--(BUSINESS WIRE)--#MDLSBioInnovation--Maryland Life Sciences, a division of the Maryland Tech Council, hosted the successful 2022 Bio Innovation Conference October 3-4 in Bethesda, Maryland. In addition to a sold-out audience, the conference featured more than 50 industry-leading speakers, 15 panel di...

San Diego, CA – June 13th, 2022 (PRWEB) June 14, 2022 -- The annual BIO International Convention, hosted by Biotechnology Innovation Organization (BIO), is

MONTREAL, June 07, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Amal Khouri, Chief Business

Investegate announcements from Knight Therapeutics, Knight to Present at the 2022 BIO International Convention in San Diego

The Maryland Tech Council announced that the 2022 Bio Innovation Conference will be held Oct. 3-4 in Montgomery County.

ZURICH, SWITZERLAND / ACCESSWIRE / February 11, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery